Cargando…
Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis
Prostate cancer is the second leading cause of cancer-related death in men. Two classic cancer hallmarks are a metabolic switch from oxidative phosphorylation (OxPhos) to glycolysis, known as the Warburg effect, and resistance to cell death. Cytochrome c (Cytc) is at the intersection of both pathway...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066186/ https://www.ncbi.nlm.nih.gov/pubmed/33916826 http://dx.doi.org/10.3390/cells10040802 |
_version_ | 1783682515754549248 |
---|---|
author | Bazylianska, Viktoriia Kalpage, Hasini A. Wan, Junmei Vaishnav, Asmita Mahapatra, Gargi Turner, Alice A. Chowdhury, Dipanwita Dutta Kim, Katherine Morse, Paul T. Lee, Icksoo Brunzelle, Joseph S. Polin, Lisa Subedi, Prabal Heath, Elisabeth I. Podgorski, Izabela Marcus, Katrin Edwards, Brian F.P. Hüttemann, Maik |
author_facet | Bazylianska, Viktoriia Kalpage, Hasini A. Wan, Junmei Vaishnav, Asmita Mahapatra, Gargi Turner, Alice A. Chowdhury, Dipanwita Dutta Kim, Katherine Morse, Paul T. Lee, Icksoo Brunzelle, Joseph S. Polin, Lisa Subedi, Prabal Heath, Elisabeth I. Podgorski, Izabela Marcus, Katrin Edwards, Brian F.P. Hüttemann, Maik |
author_sort | Bazylianska, Viktoriia |
collection | PubMed |
description | Prostate cancer is the second leading cause of cancer-related death in men. Two classic cancer hallmarks are a metabolic switch from oxidative phosphorylation (OxPhos) to glycolysis, known as the Warburg effect, and resistance to cell death. Cytochrome c (Cytc) is at the intersection of both pathways, as it is essential for electron transport in mitochondrial respiration and a trigger of intrinsic apoptosis when released from the mitochondria. However, its functional role in cancer has never been studied. Our data show that Cytc is acetylated on lysine 53 in both androgen hormone-resistant and -sensitive human prostate cancer xenografts. To characterize the functional effects of K53 modification in vitro, K53 was mutated to acetylmimetic glutamine (K53Q), and to arginine (K53R) and isoleucine (K53I) as controls. Cytochrome c oxidase (COX) activity analyzed with purified Cytc variants showed reduced oxygen consumption with acetylmimetic Cytc compared to the non-acetylated Cytc (WT), supporting the Warburg effect. In contrast to WT, K53Q Cytc had significantly lower caspase-3 activity, suggesting that modification of Cytc K53 helps cancer cells evade apoptosis. Cardiolipin peroxidase activity, which is another proapoptotic function of the protein, was lower in acetylmimetic Cytc. Acetylmimetic Cytc also had a higher capacity to scavenge reactive oxygen species (ROS), another pro-survival feature. We discuss our experimental results in light of structural features of K53Q Cytc, which we crystallized at a resolution of 1.31 Å, together with molecular dynamics simulations. In conclusion, we propose that K53 acetylation of Cytc affects two hallmarks of cancer by regulating respiration and apoptosis in prostate cancer xenografts. |
format | Online Article Text |
id | pubmed-8066186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80661862021-04-25 Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis Bazylianska, Viktoriia Kalpage, Hasini A. Wan, Junmei Vaishnav, Asmita Mahapatra, Gargi Turner, Alice A. Chowdhury, Dipanwita Dutta Kim, Katherine Morse, Paul T. Lee, Icksoo Brunzelle, Joseph S. Polin, Lisa Subedi, Prabal Heath, Elisabeth I. Podgorski, Izabela Marcus, Katrin Edwards, Brian F.P. Hüttemann, Maik Cells Article Prostate cancer is the second leading cause of cancer-related death in men. Two classic cancer hallmarks are a metabolic switch from oxidative phosphorylation (OxPhos) to glycolysis, known as the Warburg effect, and resistance to cell death. Cytochrome c (Cytc) is at the intersection of both pathways, as it is essential for electron transport in mitochondrial respiration and a trigger of intrinsic apoptosis when released from the mitochondria. However, its functional role in cancer has never been studied. Our data show that Cytc is acetylated on lysine 53 in both androgen hormone-resistant and -sensitive human prostate cancer xenografts. To characterize the functional effects of K53 modification in vitro, K53 was mutated to acetylmimetic glutamine (K53Q), and to arginine (K53R) and isoleucine (K53I) as controls. Cytochrome c oxidase (COX) activity analyzed with purified Cytc variants showed reduced oxygen consumption with acetylmimetic Cytc compared to the non-acetylated Cytc (WT), supporting the Warburg effect. In contrast to WT, K53Q Cytc had significantly lower caspase-3 activity, suggesting that modification of Cytc K53 helps cancer cells evade apoptosis. Cardiolipin peroxidase activity, which is another proapoptotic function of the protein, was lower in acetylmimetic Cytc. Acetylmimetic Cytc also had a higher capacity to scavenge reactive oxygen species (ROS), another pro-survival feature. We discuss our experimental results in light of structural features of K53Q Cytc, which we crystallized at a resolution of 1.31 Å, together with molecular dynamics simulations. In conclusion, we propose that K53 acetylation of Cytc affects two hallmarks of cancer by regulating respiration and apoptosis in prostate cancer xenografts. MDPI 2021-04-03 /pmc/articles/PMC8066186/ /pubmed/33916826 http://dx.doi.org/10.3390/cells10040802 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bazylianska, Viktoriia Kalpage, Hasini A. Wan, Junmei Vaishnav, Asmita Mahapatra, Gargi Turner, Alice A. Chowdhury, Dipanwita Dutta Kim, Katherine Morse, Paul T. Lee, Icksoo Brunzelle, Joseph S. Polin, Lisa Subedi, Prabal Heath, Elisabeth I. Podgorski, Izabela Marcus, Katrin Edwards, Brian F.P. Hüttemann, Maik Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis |
title | Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis |
title_full | Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis |
title_fullStr | Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis |
title_full_unstemmed | Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis |
title_short | Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis |
title_sort | lysine 53 acetylation of cytochrome c in prostate cancer: warburg metabolism and evasion of apoptosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066186/ https://www.ncbi.nlm.nih.gov/pubmed/33916826 http://dx.doi.org/10.3390/cells10040802 |
work_keys_str_mv | AT bazylianskaviktoriia lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT kalpagehasinia lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT wanjunmei lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT vaishnavasmita lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT mahapatragargi lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT turneralicea lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT chowdhurydipanwitadutta lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT kimkatherine lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT morsepault lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT leeicksoo lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT brunzellejosephs lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT polinlisa lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT subediprabal lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT heathelisabethi lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT podgorskiizabela lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT marcuskatrin lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT edwardsbrianfp lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis AT huttemannmaik lysine53acetylationofcytochromecinprostatecancerwarburgmetabolismandevasionofapoptosis |